Literature DB >> 19797417

Cancer incidence and incidence rates in Japan in 2003: based on data from 13 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project.

Tomohiro Matsuda1, Tomomi Marugame, Ken-Ichi Kamo, Kota Katanoda, Wakiko Ajiki, Tomotaka Sobue.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19797417     DOI： 10.1093/jjco/hyp106

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN： 0368-2811            Impact factor:   3.019


× No keyword cloud information.
  35 in total

1.  Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons.

Authors:  Hiroshi Takami; Yasuhiro Ito; Takahiro Okamoto; Akira Yoshida
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

2.  A phase I trial of arterial infusion chemotherapy with gemcitabine and 5-fluorouracil for unresectable biliary tract cancer.

Authors:  Tsuyoshi Hayashi; Hirotoshi Ishiwatari; Makoto Yoshida; Tsutomu Sato; Koji Miyanishi; Yasushi Sato; Masayoshi Kobune; Rishu Takimoto; Tomoko Sonoda; Junji Kato
Journal:  Int J Clin Oncol       Date:  2011-09-21       Impact factor: 3.402

3.  Laparoscopic versus open D2 gastrectomy for advanced gastric cancer: a retrospective cohort study.

Authors:  Toshihiko Shinohara; Seiji Satoh; Seiichiro Kanaya; Yoshinori Ishida; Keizo Taniguchi; Jun Isogaki; Kazuki Inaba; Katsuhiko Yanaga; Ichiro Uyama
Journal:  Surg Endosc       Date:  2012-06-26       Impact factor: 4.584

4.  Telomere length of gallbladder epithelium is shortened in patients with congenital biliary dilatation: measurement by quantitative fluorescence in situ hybridization.

Authors:  Yuto Aoki; Junko Aida; Youichi Kawano; Ken-Ichi Nakamura; Naotaka Izumiyama-Shimomura; Naoshi Ishikawa; Tomio Arai; Yoshiharu Nakamura; Nobuhiko Taniai; Eiji Uchida; Kaiyo Takubo; Toshiyuki Ishiwata
Journal:  J Gastroenterol       Date:  2017-11-15       Impact factor: 7.527

Review 5.  Pancreaticobiliary maljunction and biliary cancer.

Authors:  Terumi Kamisawa; Sawako Kuruma; Taku Tabata; Kazuro Chiba; Susumu Iwasaki; Satomi Koizumi; Masanao Kurata; Goro Honda; Takao Itoi
Journal:  J Gastroenterol       Date:  2014-11-18       Impact factor: 7.527

Review 6.  Biliary carcinogenesis in pancreaticobiliary maljunction.

Authors:  Terumi Kamisawa; Sawako Kuruma; Kazuro Chiba; Taku Tabata; Satomi Koizumi; Masataka Kikuyama
Journal:  J Gastroenterol       Date:  2016-10-04       Impact factor: 7.527

7.  Interaction between IGF-1 polymorphisms and overweight for the risk of pancreatic cancer in Japanese.

Authors:  Makoto Nakao; Satoyo Hosono; Hidemi Ito; Miki Watanabe; Nobumasa Mizuno; Yasushi Yatabe; Kenji Yamao; Ryuzo Ueda; Kazuo Tajima; Hideo Tanaka; Keitaro Matsuo
Journal:  Int J Mol Epidemiol Genet       Date:  2011-11-25

8.  Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective study.

Authors:  Shimpei Maeda; Fuyuhiko Motoi; Tohru Onogawa; Takanori Morikawa; Ottomo Shigeru; Naoaki Sakata; Tatsuyuki Takadate; Takeshi Naitoh; Toshiki Rikiyama; Yu Katayose; Shinichi Egawa; Michiaki Unno
Journal:  Int J Clin Oncol       Date:  2011-04-01       Impact factor: 3.402

9.  Risk factors for lower-limb lymphedema after surgery for cervical cancer.

Authors:  Yoko Ohba; Yukiharu Todo; Noriko Kobayashi; Masanori Kaneuchi; Hidemichi Watari; Mahito Takeda; Satoko Sudo; Masataka Kudo; Hidenori Kato; Noriaki Sakuragi
Journal:  Int J Clin Oncol       Date:  2011-01-07       Impact factor: 3.402

10.  Ultrasonic scalpel for gastric cancer surgery: a prospective randomized study.

Authors:  Kentaro Inoue; Yasushi Nakane; Taku Michiura; Masanori Yamada; Hiromi Mukaide; Junichi Fukui; Hirokazu Miki; Yosuke Ueyama; Richi Nakatake; Katsuji Tokuhara; Shigeyoshi Iwamoto; Hiroaki Yanagimoto; Hideyoshi Toyokawa; Sohei Satoi; A-Hon Kwon
Journal:  J Gastrointest Surg       Date:  2012-07-26       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.